We are excited to announce that Cardio.AI®, the innovative heart-health monitoring solution from XOresearch, has successfully raised $10,000 in new funding. XOresearch is at the forefront of integrating deep learning technology into real-life applications, with a strong focus on natural language processing and healthcare—a commitment that is driving significant advancements in medical device technology. Cardio.AI®, the company’s flagship product, revolutionizes cardiac monitoring by harnessing state-of-the-art deep learning algorithms to automatically annotate and interpret electrocardiograms (ECGs) captured by any legally marketed source. The product’s ability to process a full 24-hour ECG in about 30 seconds offers real-time insights and unattended cardiac monitoring, capabilities that significantly boost the productivity of clinical workflows and patient care.
The newly secured funds will be strategically invested to enhance product development and expand market reach. With a seamless integration into Electronic Health Record (EHR) systems and adaptability for mobile health devices, Cardio.AI® stands as a robust support tool for healthcare providers. Its near real-time processing empowers physicians and caregivers to better manage chronic cardiac conditions, reduce non-essential hospitalizations, and provide critical support in remote, challenging, or dangerous environments. As healthcare continues to evolve toward digital innovation, this funding further propels XOresearch’s mission to deliver scalable, AI-driven healthcare monitoring solutions that improve patient outcomes while safeguarding sensitive data. By reinforcing its commitment to enhancing cardiac care with cutting-edge technology, XOresearch is setting a new benchmark in medical support and real-time health surveillance in the modern era.
